A randomised study of outcomes in a defined group of acutely ill elderly patients managed in a geriatric assessment unit or a general medical unit

1991 ◽  
Vol 21 (2) ◽  
pp. 230-234 ◽  
Author(s):  
R. D. Harris ◽  
J. P. Chalmers ◽  
P. J. Henschke ◽  
A. Tonkin ◽  
P. Y. Popplewell ◽  
...  
2016 ◽  
Vol Volume 12 ◽  
pp. 1-9 ◽  
Author(s):  
Niklas Ekerstad ◽  
Björn Karlson ◽  
Synneve Dahlin Ivanoff ◽  
Sten Landahl ◽  
David Andersson ◽  
...  

1988 ◽  
Vol 33 (3) ◽  
pp. 273-274 ◽  
Author(s):  
B.J. Martin ◽  
J.K. McAlpine ◽  
B.L. Devine

Hypomagnesaemia and hypokalaemia are known to predispose to digoxin toxicity. Elderly patients receiving diuretics may be at special risk. A 12-month survey of all patients receiving digoxin at the time of admission to our Geriatric Assessment Unit revealed 16% were hypomagnesaemic, whereas no patient was hypokalaemic. There is a need for greater awareness of the risk of magnesium depletion in elderly patients receiving concurrent diuretic and digoxin therapy.


1994 ◽  
Vol 39 (4) ◽  
pp. 110-111 ◽  
Author(s):  
A. Hendry ◽  
A.M. Campbell ◽  
G. Campbell ◽  
J.B. Macdonald ◽  
B.O. Williams

Patients with non-rheumatic atrial fibrillation have a fivefold increased risk of stroke. Warfarin reduces this risk by approximately two thirds, but evidence for benefit from aspirin is less compelling. We assessed whether our current practice reflects the message of the trials. In a retrospective case record study we reviewed notes of 131 patients with atrial fibrillation (AF), mean age 79 (range 53–95) years, admitted to a medical unit (72) or geriatric assessment unit (59). Thirty-two patients had paroxysmal AF. Of 115 patients with nonrheumatic AF, 36 (31%) had one or more recorded contraindication to anti-coagulation. Although 79 patients (69%) had no recorded contraindication to warfarin, only 2 took warfarin and 15 aspirin prior to admission. Ten patients commenced warfarin and 8 aspirin before discharge. Thirty-nine patients (53%) without contraindication, were discharged without antithrombotic therapy. Despite evidence to support anticoagulating patients with non-rheumatic AF, this rarely occurs.


Blood ◽  
2015 ◽  
Vol 125 (13) ◽  
pp. 2068-2074 ◽  
Author(s):  
Antonio Palumbo ◽  
Sara Bringhen ◽  
Maria-Victoria Mateos ◽  
Alessandra Larocca ◽  
Thierry Facon ◽  
...  

Key Points Elderly patients with myeloma are heterogeneous and assessment strategies are needed to define the frailty profile. The proposed frailty score aims to better assess patients and provide them with more suitable therapies.


Sign in / Sign up

Export Citation Format

Share Document